Similarly, the mTOR inhibitor INK128 re-sensitized ovarian cancer cells to carboplatin-induced DNA damage by disrupting the selective translation of mRNAs involved in DNA repair and cell survival [21], highlighting the critical role of mTOR signaling in mediating resistance to DNA damage-based therapies. This evidence concerns the gene MTOR and ovarian cancer.